(NASDAQ: CDNA) Caredx's forecast annual revenue growth rate of 8.95% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 9.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 16.14%.
Caredx's revenue in 2026 is $412,820,000.On average, 11 Wall Street analysts forecast CDNA's revenue for 2026 to be $22,761,167,329, with the lowest CDNA revenue forecast at $21,772,921,457, and the highest CDNA revenue forecast at $23,595,467,947. On average, 10 Wall Street analysts forecast CDNA's revenue for 2027 to be $25,335,359,267, with the lowest CDNA revenue forecast at $24,051,621,164, and the highest CDNA revenue forecast at $26,567,954,483.
In 2028, CDNA is forecast to generate $27,841,877,285 in revenue, with the lowest revenue forecast at $25,902,580,368 and the highest revenue forecast at $29,302,807,408.